SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB) — Nov 17, 2017

Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)
Date: Nov. 17, 2017 · CIK: 0000890821 · Accession: 0001193125-17-346064

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-220499

Date
November 17, 2017
Author
/s/ Adam W. Finerman
Form
CORRESP
Company
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)

Letter

VIA EDGAR Washington, D.C. 20549 Attention: Amanda Ravitz, Assistant Director Post-Effective Amendment to Registration Statement on Form S-1 (File No. 333-220499)

Re: Ameri Holdings, Inc.

Dear Ms. Ravitz:

This letter is to confirm our discussion with respect to certain disclosure contained in the Post-Effective Amendment to the Registration Statement on Form S-1 (File No. 333-220499) of Ameri Holdings, Inc. (the “Company”) filed on November 15, 2017 (the “Post-Effective Amendment”) regarding the potential participation in the offering by Giri Devanur, one of the Company’s directors and its President and Chief Executive Officer, Dhruwa N. Rai, one of the Company’s directors, and Lone Star Value Investors, LP, a significant stockholder of the Company and an entity owned by Jeffrey E. Eberwein, the Chairman of the Company’s Board of Directors. To clarify, such disclosure, as of the time of the filing of the Post-Effective Amendment, was intended to disclose that each such party had an intention, but no agreement, to purchase securities in the offering.

Should you have any questions concerning the enclosed materials or desire any further information or clarification in respect of the Post-Effective Amendment, please do not hesitate to contact me (tel.: (212) 451-2289).

Very truly yours,
/s/ Adam W. Finerman

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 November 17, 2017

VIA EDGAR

 U.S. Securities and Exchange Commission

 100 F Street, N.E.

 Washington, D.C. 20549

Attention: Amanda Ravitz, Assistant Director

Re:
Ameri Holdings, Inc.

 Post-Effective Amendment to Registration Statement on Form S-1 (File No. 333-220499)

 Dear Ms. Ravitz:

This letter is to confirm our discussion with respect to certain disclosure contained in the Post-Effective Amendment to the Registration
Statement on Form S-1 (File No. 333-220499) of Ameri Holdings, Inc. (the “Company”) filed on November 15, 2017 (the “Post-Effective
Amendment”) regarding the potential participation in the offering by Giri Devanur, one of the Company’s directors and its President and Chief Executive Officer, Dhruwa N. Rai, one of the Company’s directors, and Lone Star Value
Investors, LP, a significant stockholder of the Company and an entity owned by Jeffrey E. Eberwein, the Chairman of the Company’s Board of Directors. To clarify, such disclosure, as of the time of the filing of the Post-Effective Amendment, was
intended to disclose that each such party had an intention, but no agreement, to purchase securities in the offering.

 Should you have any
questions concerning the enclosed materials or desire any further information or clarification in respect of the Post-Effective Amendment, please do not hesitate to contact me (tel.: (212) 451-2289).

Very truly yours,

/s/ Adam W. Finerman

Adam W. Finerman